Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
An update from Qiagen ( (QGEN) ) is now available.
Qiagen N.V. has announced a notification from the Netherlands Authority for the Financial Markets (AFM) regarding its institution, disclosing significant voting rights held by BlackRock, Inc. The notification specifies that BlackRock holds a 10.01% voting rights interest in Qiagen, primarily through indirect real holdings. This disclosure is important for stakeholders as it highlights the influence of a major financial entity within Qiagen’s shareholder structure, potentially impacting corporate governance and decision-making processes.
More about Qiagen
Qiagen N.V. operates in the biotechnology industry, specializing in providing sample and assay technologies for molecular diagnostics, applied testing, academic and pharmaceutical research. Qiagen is headquartered in Venlo, Netherlands, and is listed on stock exchanges including the NYSE and several European markets.
YTD Price Performance: 0.94%
Average Trading Volume: 871,740
Technical Sentiment Consensus Rating: Strong Sell
Current Market Cap: $9.93B
See more insights into QGEN stock on TipRanks’ Stock Analysis page.
Trending Articles
- FuboTV (NYSE:FUBO) Lawsuit Faces New Challenge from DirecTV
- Tesla’s (NASDAQ:TSLA) Elon Musk Reveals AI Training Has Reached Its Limits
- Mario Gabelli Comes Back for Files in the Paramount (NASDAQ:PARA) Merger
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
